₹171.27
+₹0.23 (+0.13%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹603 Cr
P/E
20.67
ROE
10.79%
ROCE
12.00%
About Kilitch Drugs (India) Ltd
Kilitch Drugs (India) in the manufacturing, supplying and marketing of broad range of pharmaceutical formulation in the various dosage from like Solid, Liquid and Parental across the globe with over three decades of experience.
Founded
1992
CEO
Mukund P Mehta
Employees
187
HQ
Mumbai, India
About Kilitch Drugs (India) Ltd
Kilitch Drugs (India) in the manufacturing, supplying and marketing of broad range of pharmaceutical formulation in the various dosage from like Solid, Liquid and Parental across the globe with over three decades of experience.
Founded:1992
CEO:Mukund P Mehta
Employees:187
HQ:Mumbai, India
Finished Products
1Sales
₹311.34Cr2Other operating revenues
₹1.85CrRaw Materials
1Raw Materials Consumed
₹159.52CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹220
52W Low
₹117
Volume8.92K
Avg VolumeN/A
Beta1.15
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
20.67x
Valuation
P/B Ratio
2.16x
Valuation
EPS
₹8.35
Valuation
Dividend Yield
0.00%
Valuation
ROE
10.79%
Profitability
ROCE
12.00%
Profitability
Revenue by Segment
Contribution & growth by business line
development and operations of PharmRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
A
Al-Fath Trading Corpn
Yemen
0.00% stakeForensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.32x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
15.1%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.